scholarly journals TRANSCATHETER AORTIC VALVE REPLACEMENT PATIENTS WITH ATRIAL FIBRILLATION ARE AT HIGH RISK FOR STROKE AND BLEEDING: A RATIONALE FOR CONSIDERATION OF TRANSCATHETER AORTIC VALVE REPLACEMENT AND LEFT ATRIAL APPENDAGE CLOSURE AS COMPLEMENTARY THERAPIES

2017 ◽  
Vol 69 (11) ◽  
pp. 1301
Author(s):  
Kishore J. Harjai ◽  
Eugenia Hopkins ◽  
Vernon Mascarenhas ◽  
Samuel Crockett ◽  
Deepak Singh ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Left Atrial ◽  
Transcatheter Aortic Valve Replacement ◽  
Complementary Therapies ◽  
Left Atrial Appendage ◽  
Left Atrial Appendage Closure ◽  
Transcatheter Aortic Valve

scholarly journals Transcatheter Aortic Valve Replacement and Left Atrial Appendage Occlusion – A Stitch in Time?

2011 ◽  
Vol 9 (2) ◽  
pp. 126 ◽  
Author(s):  
Sameer Gafoor ◽  
◽  
◽  
◽  
◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Left Atrial ◽  
Transcatheter Aortic Valve Replacement ◽  
Left Atrial Appendage ◽  
Atrial Appendage ◽  
Left Atrial Appendage Occlusion ◽  
Transcatheter Aortic Valve

Many patients have now been able to receive transcatheter aortic valve replacement (TAVR) therapy for severe aortic stenosis. These patients have atrial fibrillation and are placed on warfarin for stroke prophylaxis. The opportunity for treatment with left atrial appendage occlusion (LAAO) in place of warfarin for this population exists, especially for those with increased bleeding risk. This paper discusses the prevalence and aetiology of stroke in patients presenting for TAVR (with a focus on the risk from chronic and acute atrial fibrillation) and also the benefit of LAAO closure in this population.

Sign in / Sign up

Export Citation Format

Share Document